Welcome to the International Journal of Angiology, a distinguished publication dedicated to advancing the field of cardiology and cardiovascular medicine. Published by THIEME MEDICAL PUBL INC, this journal plays a crucial role in disseminating innovative research and clinical insights from 1992 through 2024, serving as a vital resource for researchers, healthcare professionals, and students alike. With an ISSN of 1061-1711 and an E-ISSN of 1615-5939, the journal currently holds a respectable Q4 ranking in the cardiology field, reflecting its commitment to quality and relevance. Although it operates under a traditional access model, the journal ensures that critical research findings are shared with a broad audience, fostering collaboration and knowledge exchange. By exploring current trends, diagnostic techniques, and treatment modalities in angiology, the International Journal of Angiology remains an essential platform for those dedicated to improving cardiovascular health around the globe.

Diabetes & Vascular Disease Research is a leading academic journal dedicated to advancing the understanding and treatment of cardiovascular and metabolic diseases, particularly diabetes. Published by SAGE Publications Ltd in the United Kingdom, this journal serves as a key resource for researchers, clinicians, and students seeking to explore the intricate relationship between diabetes and vascular health. With an impressive Impact Factor and ranked in the Q2 quartile in prominent categories such as Cardiology, Endocrinology, and Internal Medicine, the journal provides a platform for high-quality, peer-reviewed research. Covering a broad range of topics from pathophysiology to therapeutic innovations, Diabetes & Vascular Disease Research plays a vital role in shaping contemporary discourse in the field. With contributions from leading experts and a commitment to disseminating valuable findings, this journal is a must-read for anyone involved in the fight against vascular complications arising from diabetes.

Vasa - European Journal of Vascular Medicine is a leading peer-reviewed journal dedicated to advancing the field of vascular medicine, published by HOGREFE AG in Switzerland. With a proud history dating back to 1972, this journal serves as a critical platform for researchers, clinicians, and healthcare professionals committed to enhancing knowledge and practice related to cardiovascular health and vascular disorders. Holding a notable Q2 ranking in the cardiology and cardiovascular medicine category, Vasa’s scholarly contributions reflect high-quality research and innovative insights that drive clinical applications. The journal provides essential access to original articles, reviews, and case studies, fostering a vibrant exchange of ideas within the vascular medicine community. Its Scopus rank of #159 out of 387 further underscores its impact, placing it confidently in the 59th percentile among its peers. Vasa is synonymous with rigorous academic standards and relevance, making it an invaluable resource for anyone seeking to stay at the forefront of vascular research and its clinical implications.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, published by Lippincott Williams & Wilkins, is a leading journal in the field of cardiovascular medicine, dedicated to the advancement of research surrounding arterial diseases, thrombosis, and vascular biology. With an impressive impact factor indicative of its reach and influence, this journal occupies a prominent position in the Q1 category of cardiology, ranking 13th out of 387 in its field according to Scopus, placing it within the top 96th percentile among cardiovascular research journals. Since its inception in 1990, ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY has been pivotal in disseminating cutting-edge research that drives innovation and education in cardiovascular health. Although it does not operate under an open access model, the journal is a vital resource for researchers, clinicians, and students looking for high-quality, peer-reviewed articles that contribute to the understanding and treatment of cardiovascular and vascular disorders. Its commitment to rigorous scientific standards and its focus on impactful findings make it an essential publication for anyone dedicated to the field.

Vascular Pharmacology, published by Elsevier Science Inc, is a leading journal in the fields of pharmacology and molecular medicine, dedicated to advancing our understanding of vascular biology and therapeutic interventions. With an impressive impact factor reflecting its significant contribution to the scientific community, this journal seeks to publish ground-breaking research that elucidates the molecular mechanisms underlying vascular function and disease, as well as the pharmacological impact of new therapeutic agents. The journal operates under a dual access model, allowing for both subscription and open access options, ensuring that vital research is accessible to a wide audience. As of 2023, it holds a prestigious position in the Q1 category for pharmacology and ranks well in molecular medicine and physiology, reflecting its high quality and relevance. Whether you are a researcher, clinician, or student, Vascular Pharmacology serves as an essential resource to stay at the forefront of cardiovascular pharmacotherapy and vascular biology.

Welcome to the JOURNAL OF VASCULAR RESEARCH, a reputable academic journal published by KARGER that has been a cornerstone of vascular research since 1964. With an ISSN of 1018-1172 and an E-ISSN of 1423-0135, this journal plays a vital role in disseminating cutting-edge research in the fields of Cardiology and Cardiovascular Medicine and Physiology. Currently categorized in the Q3 quartile for both disciplines, it ranks as #179 in Cardiology and #131 in Physiology according to Scopus, showcasing its significant contribution to the scientific community. Although the journal operates on a subscription basis, it strives to provide accessible content that informs and inspires researchers, professionals, and students alike. As the journal looks forward to its convergence in 2024, it continues to uphold its mission of advancing knowledge, fostering innovation, and encouraging collaboration within the dynamic realm of vascular research.

HEART AND VESSELS is a prominent peer-reviewed journal published by SPRINGER, dedicated to advancing the fields of cardiology and cardiovascular medicine. With its ISSN 0910-8327 and E-ISSN 1615-2573, this esteemed journal encompasses a broad range of topics pertinent to heart health, vascular function, and associated therapies, making it an essential resource for researchers, clinicians, and healthcare professionals alike. Based in Japan and operating since 1985, HEART AND VESSELS has consistently maintained a Q2 ranking in the 2023 category quartiles, highlighting its relevance and impact in the cardio domain. Although it does not offer open access, the journal ensures high-quality publications that contribute significantly to the academic and clinical understanding of cardiovascular health. With over three decades of continuous scholarly contribution, HEART AND VESSELS serves as a vital platform for disseminating cutting-edge research and fostering innovative practices in the management of cardiovascular diseases.

ANGIOLOGY is a leading journal dedicated to the field of cardiology and cardiovascular medicine, published by SAGE Publications Inc. With a distinguished history dating back to 1950, this journal serves as an essential platform for the dissemination of cutting-edge research, innovative clinical practices, and emerging trends in cardiovascular health. Holding a respected Q2 ranking in the 2023 Scopus category for Cardiology and Cardiovascular Medicine, and positioned within the 74th percentile of its field, ANGIOLOGY is an invaluable resource for researchers, healthcare professionals, and students alike. While currently not an open-access journal, it offers subscription options to access comprehensive articles that aim to advance knowledge and improve patient care across various cardiovascular disciplines. The journal's commitment to fostering dialogue and sharing groundbreaking findings underscores its importance in the ongoing pursuit of cardiovascular excellence.

Vascular is a premier academic journal published by SAGE Publications Ltd, focusing on a wide range of disciplines within the fields of cardiology, cardiovascular medicine, surgery, and radiology. Established in 1993 and continuing through 2024, this journal serves as an essential resource for researchers and professionals seeking to advance their understanding of vascular health and disease. With an impressive categorization in the Q3 quartile for cardiology and cardiovascular medicine, and Q2 quartile for surgery, Vascular has established itself as a reputable platform for disseminating cutting-edge research and innovative clinical practices. The journal's positioning in various Scopus Ranks reflects its relevance and contribution to advancing these critical medical fields, making it an indispensable tool for students, clinicians, and researchers alike. For those interested in keeping abreast of the latest developments, Vascular offers a rich repository of articles that contribute significantly to the global discourse on vascular diseases.

Vascular Health and Risk Management is a leading peer-reviewed journal published by DOVE MEDICAL PRESS LTD, focusing on the critical areas of cardiology, endocrinology, and public health. With an impact factor that reflects its significance within the scientific community, this Open Access journal, established in 2005, has been committed to enhancing knowledge on the interplay between vascular health and various risk factors affecting patient outcomes. The journal is proudly based in New Zealand and is indexed across multiple categories, maintaining a prominent Q2 ranking in cardiology, endocrinology, diabetes, and several other medical disciplines as of 2023. By providing a platform for innovative research and comprehensive reviews, Vascular Health and Risk Management seeks to foster collaboration among healthcare professionals, enhance clinical practices, and ultimately improve patient care through rigorous scientific inquiry and disseminated knowledge. Researchers, professionals, and students will find invaluable insights that inform their work and advance the understanding of vascular-related health issues.